Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Frontiers in Immunology|July 14, 2020
Anti-dengue Vaccines: From Development to Clinical TrialsJosilene Ramos Pinheiro-Michelsen, Rayane da Silva Oliveira Souza, Itana Vivian Rocha Santana, et al.Scientific Reports|August 6, 2021
Fomites and the environment did not have an important role in COVID-19 transmission in a Brazilian mid-sized cityAna Luíza Silva Rocha, Josilene Ramos Pinheiro, Thamilin Costa Nakamura, et al.Plos One|October 3, 2012
A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent miceJaime Henrique Amorim, Raíza Sales Pereira Bizerra, Rúbens Prince dos Santos Alves, et al.Journal of Virological Methods|April 20, 2010
Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native proteinJaime Henrique Amorim, Bruna F M M Porchia, Andrea Balan, et al.Revista Da Sociedade Brasileira De Medicina Tropical|June 8, 2022
Impacts of El Niño Southern Oscillation on the dengue transmission dynamics in the Metropolitan Region of Recife, BrazilHenrique Dos Santos Ferreira, Ranyére Silva Nóbrega, Pedro Vinícius da Silva Brito, et al.Plos One|January 30, 2014
Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of actionRenata Damásio de Souza, Milene Tavares Batista, Wilson Barros Luiz, et al.Virology|October 27, 2015
Antibodies are not required to a protective immune response against dengue virus elicited in a mouse encephalitis modelJaime Henrique Amorim, Rúbens Prince dos Santos Alves, Raíza Bizerra, et al.Vaccine|December 20, 2011
Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvantJaime Henrique Amorim, Mariana Oliveira Diniz, Francisco A M O Cariri, et al.Clinical and Vaccine Immunology : CVI|April 1, 2016
Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine AntigenRúbens Prince Dos Santos Alves, Lennon Ramos Pereira, Denicar Lina Nascimento Fabris, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 14, 2025
Genetic polymorphisms in the E2 glycoprotein of chikungunya virus (2014-2023) and their potential implications for immunity and vaccine designMayanna Moreira Costa Fogaça, Milena Silva Souza, Ruth Dálety da Silva Brito, et al.Pageof 4